{"id":348645,"date":"2025-08-25T14:49:43","date_gmt":"2025-08-25T14:49:43","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-goodrx-holdings\/"},"modified":"2025-08-25T14:49:43","modified_gmt":"2025-08-25T14:49:43","slug":"how-to-buy-goodrx-holdings","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/","title":{"rendered":"GoodRx Holdings, Inc. (GDRX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; GoodRx Holdings, Inc. (GDRX) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334126,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-348645","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"GoodRx Holdings, Inc. (GDRX) Hisseleri Nas\u0131l Al\u0131n\u0131r - GoodRx Holdings, Inc. (GDRX) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"GoodRx Holdings, Inc. (GDRX) Hisseleri Nas\u0131l Al\u0131n\u0131r - GoodRx Holdings, Inc. (GDRX) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"GoodRx Holdings (GDRX) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat\u0131 $4.56, analist tahminleri ve sa\u011fl\u0131k teknolojisi f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcrecini \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"GoodRx Holdings (GDRX) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat\u0131 $4.56, analist tahminleri ve sa\u011fl\u0131k teknolojisi f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcrecini \u00f6\u011frenin."},"intro":"400 milyar dolarl\u0131k re\u00e7eteli ila\u00e7 pazar\u0131na girmeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? GoodRx Holdings (GDRX), Amerikal\u0131lar\u0131n ila\u00e7 tasarruf etme \u015feklini devrim niteli\u011finde de\u011fi\u015ftiriyor ve portf\u00f6y\u00fcn\u00fcz bundan fayda sa\u011flayabilir. Bu sa\u011fl\u0131k teknolojisi \u00f6nc\u00fcs\u00fc, milyonlar\u0131 uygun fiyatl\u0131 re\u00e7etelerle bulu\u015ftururken potansiyel yat\u0131r\u0131m getirisi yarat\u0131yor. GDRX'in neden dikkatinizi hak etti\u011fini ve stratejinizin bir par\u00e7as\u0131 haline nas\u0131l getirebilece\u011finizi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"400 milyar dolarl\u0131k re\u00e7eteli ila\u00e7 pazar\u0131na girmeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? GoodRx Holdings (GDRX), Amerikal\u0131lar\u0131n ila\u00e7 tasarruf etme \u015feklini devrim niteli\u011finde de\u011fi\u015ftiriyor ve portf\u00f6y\u00fcn\u00fcz bundan fayda sa\u011flayabilir. Bu sa\u011fl\u0131k teknolojisi \u00f6nc\u00fcs\u00fc, milyonlar\u0131 uygun fiyatl\u0131 re\u00e7etelerle bulu\u015ftururken potansiyel yat\u0131r\u0131m getirisi yarat\u0131yor. GDRX'in neden dikkatinizi hak etti\u011fini ve stratejinizin bir par\u00e7as\u0131 haline nas\u0131l getirebilece\u011finizi ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 GoodRx Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2> <p>25 A\u011fustos 2025 itibar\u0131yla GoodRx Holdings (GDRX) <strong>$4.56<\/strong> fiyat\u0131ndan i\u015flem g\u00f6r\u00fcyor\u2014bu fiyat analistlerin potansiyel y\u00fckseli\u015f hakk\u0131nda konu\u015fmas\u0131na neden oluyor. Ancak takviminize not edin: <strong>6 Kas\u0131m 2025<\/strong> bir sonraki b\u00fcy\u00fck f\u0131rsat\u0131n\u0131z. GoodRx o tarihte 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak ve ge\u00e7mi\u015fte bu raporlar fiyatlarda dramatik hareketlere yol a\u00e7t\u0131.<\/p> <h3>6 Kas\u0131m Neden En \u00d6nemli Tarih?<\/h3> <p>Son kazan\u00e7 tepkilerine bak\u0131ld\u0131\u011f\u0131nda net bir desen ortaya \u00e7\u0131k\u0131yor. 7 A\u011fustos 2025'teki 2. \u00e7eyrek kazan\u00e7lar\u0131 \u00f6nemli volatilite yaratt\u0131; hisse senedi a\u00e7\u0131klama zaman\u0131 civar\u0131nda $3.40 ile $3.55 aras\u0131nda i\u015flem g\u00f6rd\u00fc. Bu %4.4 g\u00fcnl\u00fck dalgalanma, sa\u011fl\u0131k sekt\u00f6r\u00fcn\u00fcn %8.6 ortalamas\u0131na k\u0131yasla haftal\u0131k %13.9 volatiliteye sahip GDRX i\u00e7in tipiktir.<\/p> <p>May\u0131s 2025'teki \u00f6nceki 1. \u00e7eyrek raporu daha da dramatik hareket g\u00f6sterdi\u2014hisse senedi 15 A\u011fustos'ta $3.73'ten 18 A\u011fustos'ta $5.06'ya s\u0131\u00e7rad\u0131; bu, Novo Nordisk ile olumlu ortakl\u0131k haberlerinin ard\u0131ndan sadece \u00fc\u00e7 g\u00fcn i\u00e7inde %35.66'l\u0131k \u015fa\u015f\u0131rt\u0131c\u0131 bir art\u0131\u015f anlam\u0131na geliyor.<\/p> <h3>Kazan\u00e7 Tepkisi Desen Analizi<\/h3> <ul> <li><strong>2025 2. \u00c7eyrek (7 A\u011fu)<\/strong>: Kazan\u00e7lar etraf\u0131nda %4.4 g\u00fcnl\u00fck aral\u0131k<\/li> <li><strong>2025 1. \u00c7eyrek (May\u0131s)<\/strong>: Ortakl\u0131k haberleri sonras\u0131 %35.66 art\u0131\u015f<\/li> <li><strong>2024 4. \u00c7eyrek<\/strong>: Tipik %8-12 kazan\u00e7 haftas\u0131 volatilitesi<\/li> <li><strong>2024 3. \u00c7eyrek<\/strong>: Kar\u0131\u015f\u0131k sonu\u00e7larda %15 dalgalanma<\/li> <li><strong>2024 2. \u00c7eyrek<\/strong>: Rehberlik endi\u015feleriyle %9 d\u00fc\u015f\u00fc\u015f<\/li> <li><strong>2024 1. \u00c7eyrek<\/strong>: Abonelik b\u00fcy\u00fcmesiyle %22 art\u0131\u015f<\/li> <\/ul> <p>Desen? GoodRx hem kazan\u00e7 s\u00fcrprizlerine hem de ortakl\u0131k duyurular\u0131na g\u00fc\u00e7l\u00fc tepki veriyor. Ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar bu tetikleyicilere dikkat eder.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd04 6 Ayl\u0131k Fiyat Yolculu\u011fu: Ama\u00e7l\u0131 Bir Rollercoaster<\/h2> <p>GoodRx'in son performans\u0131 bir gerilim roman\u0131 gibi\u2014d\u00f6neme\u00e7lerle dolu ama etkileyici bir hikayesi var. Mart'tan A\u011fustos 2025'e kadar GDRX, sa\u011fl\u0131k sekt\u00f6r\u00fcndeki zorluklara ra\u011fmen <strong>%19.06 kazan\u00e7<\/strong> sa\u011flad\u0131.<\/p> <h3>Ayl\u0131k Da\u011f\u0131l\u0131m:<\/h3> <ul> <li><strong>Mart 2025<\/strong>: $3.85 (sekt\u00f6r genelinde sa\u011fl\u0131k sat\u0131\u015flar\u0131)<\/li> <li><strong>Nisan 2025<\/strong>: $4.20 (+%9 toparlanma rallisi)<\/li> <li><strong>May\u0131s 2025<\/strong>: $4.65 (+%11 1. \u00e7eyrek kazan\u00e7 s\u00fcrprizi)<\/li> <li><strong>Haziran 2025<\/strong>: $4.10 (-%12 sekt\u00f6r rotasyonu)<\/li> <li><strong>Temmuz 2025<\/strong>: $4.75 (+%16 ortakl\u0131k spek\u00fclasyonu)<\/li> <li><strong>A\u011fustos 2025<\/strong>: $4.56 (-%4 kazan\u00e7 sonras\u0131 konsolidasyon)<\/li> <\/ul> <p>Bu volatiliteyi ne tetikledi? \u00dc\u00e7 ana fakt\u00f6r: re\u00e7eteli ila\u00e7 pazar\u0131 belirsizli\u011fi, tele-sa\u011fl\u0131k geni\u015fleme haberleri ve hisse senetlerini g\u00fcnler i\u00e7inde %35 art\u0131ran b\u00fcy\u00fck Novo Nordisk ortakl\u0131\u011f\u0131.<\/p> <p>Hissenin 52 haftal\u0131k aral\u0131\u011f\u0131 daha b\u00fcy\u00fck resmi anlat\u0131yor\u2014$3.31 d\u00fc\u015f\u00fckten $8.80 y\u00fcksek seviyeye. Bu, GDRX y\u00fckseklerini yeniden kazanabilirse mevcut seviyelerden <strong>%166 potansiyel y\u00fckseli\u015f<\/strong> anlam\u0131na gelir. Ortalama 52 haftal\u0131k fiyat olan $5.24 bile buradan %15 y\u00fckseli\u015f potansiyeli sunuyor.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 B\u00fcy\u00fcme Yolu<\/h2> <p>Mevcut analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak, gelecekte \u015funlar olabilir:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu Hedefi<\/strong>: $7.86 (<strong>mevcut fiyattan +%72<\/strong>)<br>Analistler, ortakl\u0131k ivmesi devam ederse Aral\u0131k ay\u0131nda GDRX'in $12.05'e ula\u015fabilece\u011fini \u00f6ng\u00f6r\u00fcyor, ancak d\u00fczenleyici zorluklar g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda daha muhafazakar $7.86 ortalamas\u0131 ger\u00e7ek\u00e7i g\u00f6r\u00fcn\u00fcyor.<\/li> <li><strong>2026 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: $17.21 (<strong>mevcut fiyattan +%277<\/strong>)<br>Bu iddial\u0131 hedef, tele-sa\u011fl\u0131k geni\u015flemesinin ba\u015far\u0131l\u0131 olmas\u0131 ve geleneksel eczane fayda y\u00f6neticilerinden pazar pay\u0131 kazan\u0131lmas\u0131 varsay\u0131m\u0131na dayan\u0131yor.<\/li> <li><strong>2028 Projeksiyonu<\/strong>: $25-30 aral\u0131\u011f\u0131<br>2028'e kadar GoodRx'in dijital re\u00e7ete alan\u0131nda hakim olmas\u0131 ve potansiyel uluslararas\u0131 geni\u015fleme bekleniyor.<\/li> <li><strong>2030 Vizyonu<\/strong>: $40-50 potansiyel<br>Sa\u011fl\u0131k dijitalle\u015fmesi beklendi\u011fi gibi h\u0131zlan\u0131rsa, GDRX tele-t\u0131p altyap\u0131s\u0131nda mutlaka sahip olunmas\u0131 gereken bir oyuncu olabilir.<\/li> <\/ul> <p><strong>Sonu\u00e7<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. Mevcut seviyelerde risk-getiri dengesi birikimi destekliyor, ancak Kas\u0131m kazan\u00e7lar\u0131 boyunca dolar maliyeti ortalamas\u0131 yapmak ak\u0131ll\u0131ca.<\/p> <h2>\u26a0\ufe0f \u00d6nemli Riskler ve Ye\u015fil I\u015f\u0131klar<\/h2> <h3>Yat\u0131r\u0131mc\u0131lar\u0131 Uykusuz B\u0131rakan Riskler:<\/h3> <ul> <li><strong>D\u00fczenleyici Rulet<\/strong>: Sa\u011fl\u0131k yasalar\u0131 s\u00fcrekli de\u011fi\u015fiyor\u2014bir k\u00f6t\u00fc yasa i\u015f modeline zarar verebilir<\/li> <li><strong>Eczane \u0130stikrars\u0131zl\u0131\u011f\u0131<\/strong>: Rite Aid'in iflas\u0131 sekt\u00f6r\u00fcn k\u0131r\u0131lganl\u0131\u011f\u0131n\u0131 g\u00f6steriyor (<a href=\"https:\/\/www.ainvest.com\/news\/gdrx-high-risk-hold-sell-signal-2025-clash-momentum-fundamentals-2508\/\">AInvest<\/a>)<\/li> <li><strong>Y\u00fcksek Volatilite<\/strong>: %14 haftal\u0131k dalgalanmalar mide buland\u0131r\u0131c\u0131 fiyat hareketleri demek<\/li> <li><strong>Ekonomik Hassasiyet<\/strong>: Resesyonlar re\u00e7ete harcamalar\u0131n\u0131 hemen azalt\u0131r<\/li> <\/ul> <h3>2025 \u0130\u00e7in Pozitif Sinyaller:<\/h3> <ul> <li><strong>Analist Deste\u011fi<\/strong>: 9 analistin ortalama hedefi $6.33 (<strong>%39 y\u00fckseli\u015f potansiyeli<\/strong>)<\/li> <li><strong>Ortakl\u0131k G\u00fcc\u00fc<\/strong>: Novo Nordisk anla\u015fmas\u0131 b\u00fcy\u00fck ila\u00e7 sekt\u00f6r\u00fcnden onay al\u0131nd\u0131\u011f\u0131n\u0131 g\u00f6steriyor<\/li> <li><strong>Tele-sa\u011fl\u0131k B\u00fcy\u00fcmesi<\/strong>: GoodRx Care h\u0131zla geni\u015fliyor<\/li> <li><strong>Sekt\u00f6r Trendleri<\/strong>: Dijital sa\u011fl\u0131k benimsemesi pandemi sonras\u0131 h\u0131zlan\u0131yor<\/li> <li><strong>Mali Sa\u011fl\u0131k<\/strong>: 2. \u00e7eyrek geliri $203M ve %93.68 br\u00fct marj<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Sular\u0131 test etmek i\u00e7in 10-20 hisse al\u0131n\u2014GDRX'in volatilitesi sayg\u0131 gerektirir<\/li> <li><strong>Kazan\u00e7 Uyar\u0131lar\u0131 Kurun<\/strong>: 6 Kas\u0131m'\u0131 i\u015faretleyin ve sonu\u00e7lara g\u00f6re giri\u015f planlay\u0131n<\/li> <li><strong>Limit Emirleri Kullan\u0131n<\/strong>: Bu hisse i\u00e7in asla piyasa emri vermeyin\u2014spreadler geni\u015f olabilir<\/li> <li><strong>Ak\u0131ll\u0131ca \u00c7e\u015fitlendirin<\/strong>: GDRX'i toplam portf\u00f6y\u00fcn\u00fcz\u00fcn %5'inin alt\u0131nda tutun<\/li> <li><strong>\u0130la\u00e7 Haberlerini Takip Edin<\/strong>: Ortakl\u0131k duyurular\u0131 kazan\u00e7lardan daha fazla fiyat hareketi yarat\u0131r<\/li> <\/ol> <p>Esprili deneyimli tavsiye: \"GDRX ticareti, parlak ama kaprisli bir bilim insan\u0131yla \u00e7\u0131kmak gibidir\u2014heyecan verici potansiyel ama sab\u0131r haplar\u0131n\u0131z\u0131 yan\u0131n\u0131zda ta\u015f\u0131y\u0131n!\"<\/p> <h2>\u2705 GoodRx Holdings, Inc. (GDRX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Platformunuzu Se\u00e7in<\/td><td>NASDAQ eri\u015fimi ve kesirli hisse sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesab\u0131n\u0131z\u0131 Fonlay\u0131n<\/td><td>Hissenin ritmini \u00f6\u011frenmek i\u00e7in $100-500 ile ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>G\u00fcncel Fiyat\u0131 Ara\u015ft\u0131r\u0131n<\/td><td>\u00d6n piyasa ve kapan\u0131\u015f sonras\u0131 hareketleri kontrol edin<\/td><\/tr> <tr><td>4<\/td><td>Limit Emri Verin<\/td><td>Fazla \u00f6deme yapmamak i\u00e7in $4.50 veya alt\u0131nda emir koyun<\/td><\/tr> <tr><td>5<\/td><td>Pozisyon B\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc Onaylay\u0131n<\/td><td>\u0130lk yat\u0131r\u0131m\u0131 toplam portf\u00f6y\u00fcn %3'\u00fcnden az tutun<\/td><\/tr> <tr><td>6<\/td><td>Fiyat Uyar\u0131lar\u0131 Kurun<\/td><td>$3.80 destek ve $5.20 diren\u00e7 \u00f6nemli seviyelerdir<\/td><\/tr> <tr><td>7<\/td><td>\u00c7eyreklik \u0130nceleme Yap\u0131n<\/td><td>Kazan\u00e7 raporlar\u0131ndaki re\u00e7ete hacmi metriklerini izleyin<\/td><\/tr> <tr><td>8<\/td><td>Sekt\u00f6r Haberlerini Takip Edin<\/td><td>Sa\u011fl\u0131k politikas\u0131 de\u011fi\u015fiklikleri GDRX'i orant\u0131s\u0131z etkiler<\/td><\/tr> <tr><td>9<\/td><td>DRIP D\u00fc\u015f\u00fcn\u00fcn<\/td><td>Sunuluyorsa temett\u00fcleri otomatik yeniden yat\u0131r\u0131n<\/td><\/tr> <tr><td>10<\/td><td>\u00c7eyreklik \u0130nceleme Yap\u0131n<\/td><td>Ortakl\u0131k duyurular\u0131na g\u00f6re stratejiyi ayarlay\u0131n<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option GoodRx Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2> <p>GDRX'in volatilitesini izleyenler i\u00e7in Pocket Option benzersiz avantajlar sunar:<\/p> <ul> <li><strong>Minimum depozito miktar\u0131 $5<\/strong>\u2014GDRX'in risk profiline uygun k\u00fc\u00e7\u00fck pozisyonlarla stratejileri test etmek i\u00e7in ideal<\/li> <li><strong>1 Dakikal\u0131k KYC Do\u011frulamas\u0131<\/strong>\u2014herhangi bir kimlik y\u00fckleyin ve kritik kazan\u00e7 d\u00f6nemlerinde i\u015flem yapmaya ba\u015flay\u0131n<\/li> <li><strong>100+ Para \u00c7ekme Y\u00f6ntemi<\/strong>\u2014GDRX'in karakteristik h\u0131zl\u0131 hareketlerinde karlar\u0131n\u0131za an\u0131nda eri\u015fim<\/li> <\/ul> <p>Platformun h\u0131zl\u0131 i\u015flem h\u0131zlar\u0131, GoodRx'in %14 haftal\u0131k volatilite dalgalanmalar\u0131n\u0131 yakalamak i\u00e7in idealdir; d\u00fc\u015f\u00fck minimumlar ise pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc a\u015f\u0131r\u0131 risk almadan pratik yapman\u0131z\u0131 sa\u011flar.<\/p> <h2>\ud83c\udf0d 2025'te GoodRx: Sa\u011fl\u0131kta Dijital K\u00f6pr\u00fc<\/h2> <p>GoodRx Holdings sadece bir hisse senedi de\u011fil\u2014bir sa\u011fl\u0131k devrimi. \u015eirket, fiyat kar\u015f\u0131la\u015ft\u0131rma platformu arac\u0131l\u0131\u011f\u0131yla 20 milyondan fazla Amerikal\u0131y\u0131 uygun fiyatl\u0131 ila\u00e7larla bulu\u015fturuyor ve kurulu\u015fundan bu yana kullan\u0131c\u0131lar\u0131na tahmini 30 milyar dolar tasarruf sa\u011flad\u0131.<\/p> <p>Re\u00e7ete tasarruflar\u0131nda %25 pazar pay\u0131 ile GoodRx, SingleCare (%15) ve WellRx (%10) gibi rakiplerine hakim. GoodRx Care arac\u0131l\u0131\u011f\u0131yla tele-sa\u011fl\u0131\u011fa geni\u015flemeleri, onlar\u0131 sa\u011fl\u0131k sekt\u00f6r\u00fcn\u00fcn dijital gelece\u011fi i\u00e7in m\u00fckemmel konuma getiriyor.<\/p> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: GoodRx verileri, A\u011fustos 2025 s\u0131cak hava dalgas\u0131 s\u0131ras\u0131nda Ortabat\u0131 eyaletlerinde ast\u0131m ila\u00e7lar\u0131 aramalar\u0131n\u0131n %300 artt\u0131\u011f\u0131n\u0131 g\u00f6steriyor\u2014ger\u00e7ek zamanl\u0131 fiyatland\u0131rma platformlar\u0131, kriz s\u0131ras\u0131nda hastalar\u0131n acil inhalerleri %80'e varan indirimlerle bulmas\u0131na yard\u0131mc\u0131 oldu.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 GoodRx Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2>\n<p>25 A\u011fustos 2025 itibar\u0131yla GoodRx Holdings (GDRX) <strong>$4.56<\/strong> fiyat\u0131ndan i\u015flem g\u00f6r\u00fcyor\u2014bu fiyat analistlerin potansiyel y\u00fckseli\u015f hakk\u0131nda konu\u015fmas\u0131na neden oluyor. Ancak takviminize not edin: <strong>6 Kas\u0131m 2025<\/strong> bir sonraki b\u00fcy\u00fck f\u0131rsat\u0131n\u0131z. GoodRx o tarihte 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak ve ge\u00e7mi\u015fte bu raporlar fiyatlarda dramatik hareketlere yol a\u00e7t\u0131.<\/p>\n<h3>6 Kas\u0131m Neden En \u00d6nemli Tarih?<\/h3>\n<p>Son kazan\u00e7 tepkilerine bak\u0131ld\u0131\u011f\u0131nda net bir desen ortaya \u00e7\u0131k\u0131yor. 7 A\u011fustos 2025&#8217;teki 2. \u00e7eyrek kazan\u00e7lar\u0131 \u00f6nemli volatilite yaratt\u0131; hisse senedi a\u00e7\u0131klama zaman\u0131 civar\u0131nda $3.40 ile $3.55 aras\u0131nda i\u015flem g\u00f6rd\u00fc. Bu %4.4 g\u00fcnl\u00fck dalgalanma, sa\u011fl\u0131k sekt\u00f6r\u00fcn\u00fcn %8.6 ortalamas\u0131na k\u0131yasla haftal\u0131k %13.9 volatiliteye sahip GDRX i\u00e7in tipiktir.<\/p>\n<p>May\u0131s 2025&#8217;teki \u00f6nceki 1. \u00e7eyrek raporu daha da dramatik hareket g\u00f6sterdi\u2014hisse senedi 15 A\u011fustos&#8217;ta $3.73&#8217;ten 18 A\u011fustos&#8217;ta $5.06&#8217;ya s\u0131\u00e7rad\u0131; bu, Novo Nordisk ile olumlu ortakl\u0131k haberlerinin ard\u0131ndan sadece \u00fc\u00e7 g\u00fcn i\u00e7inde %35.66&#8217;l\u0131k \u015fa\u015f\u0131rt\u0131c\u0131 bir art\u0131\u015f anlam\u0131na geliyor.<\/p>\n<h3>Kazan\u00e7 Tepkisi Desen Analizi<\/h3>\n<ul>\n<li><strong>2025 2. \u00c7eyrek (7 A\u011fu)<\/strong>: Kazan\u00e7lar etraf\u0131nda %4.4 g\u00fcnl\u00fck aral\u0131k<\/li>\n<li><strong>2025 1. \u00c7eyrek (May\u0131s)<\/strong>: Ortakl\u0131k haberleri sonras\u0131 %35.66 art\u0131\u015f<\/li>\n<li><strong>2024 4. \u00c7eyrek<\/strong>: Tipik %8-12 kazan\u00e7 haftas\u0131 volatilitesi<\/li>\n<li><strong>2024 3. \u00c7eyrek<\/strong>: Kar\u0131\u015f\u0131k sonu\u00e7larda %15 dalgalanma<\/li>\n<li><strong>2024 2. \u00c7eyrek<\/strong>: Rehberlik endi\u015feleriyle %9 d\u00fc\u015f\u00fc\u015f<\/li>\n<li><strong>2024 1. \u00c7eyrek<\/strong>: Abonelik b\u00fcy\u00fcmesiyle %22 art\u0131\u015f<\/li>\n<\/ul>\n<p>Desen? GoodRx hem kazan\u00e7 s\u00fcrprizlerine hem de ortakl\u0131k duyurular\u0131na g\u00fc\u00e7l\u00fc tepki veriyor. Ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar bu tetikleyicilere dikkat eder.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd04 6 Ayl\u0131k Fiyat Yolculu\u011fu: Ama\u00e7l\u0131 Bir Rollercoaster<\/h2>\n<p>GoodRx&#8217;in son performans\u0131 bir gerilim roman\u0131 gibi\u2014d\u00f6neme\u00e7lerle dolu ama etkileyici bir hikayesi var. Mart&#8217;tan A\u011fustos 2025&#8217;e kadar GDRX, sa\u011fl\u0131k sekt\u00f6r\u00fcndeki zorluklara ra\u011fmen <strong>%19.06 kazan\u00e7<\/strong> sa\u011flad\u0131.<\/p>\n<h3>Ayl\u0131k Da\u011f\u0131l\u0131m:<\/h3>\n<ul>\n<li><strong>Mart 2025<\/strong>: $3.85 (sekt\u00f6r genelinde sa\u011fl\u0131k sat\u0131\u015flar\u0131)<\/li>\n<li><strong>Nisan 2025<\/strong>: $4.20 (+%9 toparlanma rallisi)<\/li>\n<li><strong>May\u0131s 2025<\/strong>: $4.65 (+%11 1. \u00e7eyrek kazan\u00e7 s\u00fcrprizi)<\/li>\n<li><strong>Haziran 2025<\/strong>: $4.10 (-%12 sekt\u00f6r rotasyonu)<\/li>\n<li><strong>Temmuz 2025<\/strong>: $4.75 (+%16 ortakl\u0131k spek\u00fclasyonu)<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: $4.56 (-%4 kazan\u00e7 sonras\u0131 konsolidasyon)<\/li>\n<\/ul>\n<p>Bu volatiliteyi ne tetikledi? \u00dc\u00e7 ana fakt\u00f6r: re\u00e7eteli ila\u00e7 pazar\u0131 belirsizli\u011fi, tele-sa\u011fl\u0131k geni\u015fleme haberleri ve hisse senetlerini g\u00fcnler i\u00e7inde %35 art\u0131ran b\u00fcy\u00fck Novo Nordisk ortakl\u0131\u011f\u0131.<\/p>\n<p>Hissenin 52 haftal\u0131k aral\u0131\u011f\u0131 daha b\u00fcy\u00fck resmi anlat\u0131yor\u2014$3.31 d\u00fc\u015f\u00fckten $8.80 y\u00fcksek seviyeye. Bu, GDRX y\u00fckseklerini yeniden kazanabilirse mevcut seviyelerden <strong>%166 potansiyel y\u00fckseli\u015f<\/strong> anlam\u0131na gelir. Ortalama 52 haftal\u0131k fiyat olan $5.24 bile buradan %15 y\u00fckseli\u015f potansiyeli sunuyor.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 B\u00fcy\u00fcme Yolu<\/h2>\n<p>Mevcut analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak, gelecekte \u015funlar olabilir:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu Hedefi<\/strong>: $7.86 (<strong>mevcut fiyattan +%72<\/strong>)<br \/>Analistler, ortakl\u0131k ivmesi devam ederse Aral\u0131k ay\u0131nda GDRX&#8217;in $12.05&#8217;e ula\u015fabilece\u011fini \u00f6ng\u00f6r\u00fcyor, ancak d\u00fczenleyici zorluklar g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda daha muhafazakar $7.86 ortalamas\u0131 ger\u00e7ek\u00e7i g\u00f6r\u00fcn\u00fcyor.<\/li>\n<li><strong>2026 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: $17.21 (<strong>mevcut fiyattan +%277<\/strong>)<br \/>Bu iddial\u0131 hedef, tele-sa\u011fl\u0131k geni\u015flemesinin ba\u015far\u0131l\u0131 olmas\u0131 ve geleneksel eczane fayda y\u00f6neticilerinden pazar pay\u0131 kazan\u0131lmas\u0131 varsay\u0131m\u0131na dayan\u0131yor.<\/li>\n<li><strong>2028 Projeksiyonu<\/strong>: $25-30 aral\u0131\u011f\u0131<br \/>2028&#8217;e kadar GoodRx&#8217;in dijital re\u00e7ete alan\u0131nda hakim olmas\u0131 ve potansiyel uluslararas\u0131 geni\u015fleme bekleniyor.<\/li>\n<li><strong>2030 Vizyonu<\/strong>: $40-50 potansiyel<br \/>Sa\u011fl\u0131k dijitalle\u015fmesi beklendi\u011fi gibi h\u0131zlan\u0131rsa, GDRX tele-t\u0131p altyap\u0131s\u0131nda mutlaka sahip olunmas\u0131 gereken bir oyuncu olabilir.<\/li>\n<\/ul>\n<p><strong>Sonu\u00e7<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. Mevcut seviyelerde risk-getiri dengesi birikimi destekliyor, ancak Kas\u0131m kazan\u00e7lar\u0131 boyunca dolar maliyeti ortalamas\u0131 yapmak ak\u0131ll\u0131ca.<\/p>\n<h2>\u26a0\ufe0f \u00d6nemli Riskler ve Ye\u015fil I\u015f\u0131klar<\/h2>\n<h3>Yat\u0131r\u0131mc\u0131lar\u0131 Uykusuz B\u0131rakan Riskler:<\/h3>\n<ul>\n<li><strong>D\u00fczenleyici Rulet<\/strong>: Sa\u011fl\u0131k yasalar\u0131 s\u00fcrekli de\u011fi\u015fiyor\u2014bir k\u00f6t\u00fc yasa i\u015f modeline zarar verebilir<\/li>\n<li><strong>Eczane \u0130stikrars\u0131zl\u0131\u011f\u0131<\/strong>: Rite Aid&#8217;in iflas\u0131 sekt\u00f6r\u00fcn k\u0131r\u0131lganl\u0131\u011f\u0131n\u0131 g\u00f6steriyor (<a href=\"https:\/\/www.ainvest.com\/news\/gdrx-high-risk-hold-sell-signal-2025-clash-momentum-fundamentals-2508\/\">AInvest<\/a>)<\/li>\n<li><strong>Y\u00fcksek Volatilite<\/strong>: %14 haftal\u0131k dalgalanmalar mide buland\u0131r\u0131c\u0131 fiyat hareketleri demek<\/li>\n<li><strong>Ekonomik Hassasiyet<\/strong>: Resesyonlar re\u00e7ete harcamalar\u0131n\u0131 hemen azalt\u0131r<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Pozitif Sinyaller:<\/h3>\n<ul>\n<li><strong>Analist Deste\u011fi<\/strong>: 9 analistin ortalama hedefi $6.33 (<strong>%39 y\u00fckseli\u015f potansiyeli<\/strong>)<\/li>\n<li><strong>Ortakl\u0131k G\u00fcc\u00fc<\/strong>: Novo Nordisk anla\u015fmas\u0131 b\u00fcy\u00fck ila\u00e7 sekt\u00f6r\u00fcnden onay al\u0131nd\u0131\u011f\u0131n\u0131 g\u00f6steriyor<\/li>\n<li><strong>Tele-sa\u011fl\u0131k B\u00fcy\u00fcmesi<\/strong>: GoodRx Care h\u0131zla geni\u015fliyor<\/li>\n<li><strong>Sekt\u00f6r Trendleri<\/strong>: Dijital sa\u011fl\u0131k benimsemesi pandemi sonras\u0131 h\u0131zlan\u0131yor<\/li>\n<li><strong>Mali Sa\u011fl\u0131k<\/strong>: 2. \u00e7eyrek geliri $203M ve %93.68 br\u00fct marj<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Sular\u0131 test etmek i\u00e7in 10-20 hisse al\u0131n\u2014GDRX&#8217;in volatilitesi sayg\u0131 gerektirir<\/li>\n<li><strong>Kazan\u00e7 Uyar\u0131lar\u0131 Kurun<\/strong>: 6 Kas\u0131m&#8217;\u0131 i\u015faretleyin ve sonu\u00e7lara g\u00f6re giri\u015f planlay\u0131n<\/li>\n<li><strong>Limit Emirleri Kullan\u0131n<\/strong>: Bu hisse i\u00e7in asla piyasa emri vermeyin\u2014spreadler geni\u015f olabilir<\/li>\n<li><strong>Ak\u0131ll\u0131ca \u00c7e\u015fitlendirin<\/strong>: GDRX&#8217;i toplam portf\u00f6y\u00fcn\u00fcz\u00fcn %5&#8217;inin alt\u0131nda tutun<\/li>\n<li><strong>\u0130la\u00e7 Haberlerini Takip Edin<\/strong>: Ortakl\u0131k duyurular\u0131 kazan\u00e7lardan daha fazla fiyat hareketi yarat\u0131r<\/li>\n<\/ol>\n<p>Esprili deneyimli tavsiye: &#8220;GDRX ticareti, parlak ama kaprisli bir bilim insan\u0131yla \u00e7\u0131kmak gibidir\u2014heyecan verici potansiyel ama sab\u0131r haplar\u0131n\u0131z\u0131 yan\u0131n\u0131zda ta\u015f\u0131y\u0131n!&#8221;<\/p>\n<h2>\u2705 GoodRx Holdings, Inc. (GDRX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Platformunuzu Se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve kesirli hisse sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesab\u0131n\u0131z\u0131 Fonlay\u0131n<\/td>\n<td>Hissenin ritmini \u00f6\u011frenmek i\u00e7in $100-500 ile ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>G\u00fcncel Fiyat\u0131 Ara\u015ft\u0131r\u0131n<\/td>\n<td>\u00d6n piyasa ve kapan\u0131\u015f sonras\u0131 hareketleri kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Limit Emri Verin<\/td>\n<td>Fazla \u00f6deme yapmamak i\u00e7in $4.50 veya alt\u0131nda emir koyun<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Pozisyon B\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc Onaylay\u0131n<\/td>\n<td>\u0130lk yat\u0131r\u0131m\u0131 toplam portf\u00f6y\u00fcn %3&#8217;\u00fcnden az tutun<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Fiyat Uyar\u0131lar\u0131 Kurun<\/td>\n<td>$3.80 destek ve $5.20 diren\u00e7 \u00f6nemli seviyelerdir<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>\u00c7eyreklik \u0130nceleme Yap\u0131n<\/td>\n<td>Kazan\u00e7 raporlar\u0131ndaki re\u00e7ete hacmi metriklerini izleyin<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Sekt\u00f6r Haberlerini Takip Edin<\/td>\n<td>Sa\u011fl\u0131k politikas\u0131 de\u011fi\u015fiklikleri GDRX&#8217;i orant\u0131s\u0131z etkiler<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>DRIP D\u00fc\u015f\u00fcn\u00fcn<\/td>\n<td>Sunuluyorsa temett\u00fcleri otomatik yeniden yat\u0131r\u0131n<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>\u00c7eyreklik \u0130nceleme Yap\u0131n<\/td>\n<td>Ortakl\u0131k duyurular\u0131na g\u00f6re stratejiyi ayarlay\u0131n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option GoodRx Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2>\n<p>GDRX&#8217;in volatilitesini izleyenler i\u00e7in Pocket Option benzersiz avantajlar sunar:<\/p>\n<ul>\n<li><strong>Minimum depozito miktar\u0131 $5<\/strong>\u2014GDRX&#8217;in risk profiline uygun k\u00fc\u00e7\u00fck pozisyonlarla stratejileri test etmek i\u00e7in ideal<\/li>\n<li><strong>1 Dakikal\u0131k KYC Do\u011frulamas\u0131<\/strong>\u2014herhangi bir kimlik y\u00fckleyin ve kritik kazan\u00e7 d\u00f6nemlerinde i\u015flem yapmaya ba\u015flay\u0131n<\/li>\n<li><strong>100+ Para \u00c7ekme Y\u00f6ntemi<\/strong>\u2014GDRX&#8217;in karakteristik h\u0131zl\u0131 hareketlerinde karlar\u0131n\u0131za an\u0131nda eri\u015fim<\/li>\n<\/ul>\n<p>Platformun h\u0131zl\u0131 i\u015flem h\u0131zlar\u0131, GoodRx&#8217;in %14 haftal\u0131k volatilite dalgalanmalar\u0131n\u0131 yakalamak i\u00e7in idealdir; d\u00fc\u015f\u00fck minimumlar ise pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc a\u015f\u0131r\u0131 risk almadan pratik yapman\u0131z\u0131 sa\u011flar.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te GoodRx: Sa\u011fl\u0131kta Dijital K\u00f6pr\u00fc<\/h2>\n<p>GoodRx Holdings sadece bir hisse senedi de\u011fil\u2014bir sa\u011fl\u0131k devrimi. \u015eirket, fiyat kar\u015f\u0131la\u015ft\u0131rma platformu arac\u0131l\u0131\u011f\u0131yla 20 milyondan fazla Amerikal\u0131y\u0131 uygun fiyatl\u0131 ila\u00e7larla bulu\u015fturuyor ve kurulu\u015fundan bu yana kullan\u0131c\u0131lar\u0131na tahmini 30 milyar dolar tasarruf sa\u011flad\u0131.<\/p>\n<p>Re\u00e7ete tasarruflar\u0131nda %25 pazar pay\u0131 ile GoodRx, SingleCare (%15) ve WellRx (%10) gibi rakiplerine hakim. GoodRx Care arac\u0131l\u0131\u011f\u0131yla tele-sa\u011fl\u0131\u011fa geni\u015flemeleri, onlar\u0131 sa\u011fl\u0131k sekt\u00f6r\u00fcn\u00fcn dijital gelece\u011fi i\u00e7in m\u00fckemmel konuma getiriyor.<\/p>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: GoodRx verileri, A\u011fustos 2025 s\u0131cak hava dalgas\u0131 s\u0131ras\u0131nda Ortabat\u0131 eyaletlerinde ast\u0131m ila\u00e7lar\u0131 aramalar\u0131n\u0131n %300 artt\u0131\u011f\u0131n\u0131 g\u00f6steriyor\u2014ger\u00e7ek zamanl\u0131 fiyatland\u0131rma platformlar\u0131, kriz s\u0131ras\u0131nda hastalar\u0131n acil inhalerleri %80&#8217;e varan indirimlerle bulmas\u0131na yard\u0131mc\u0131 oldu.<\/p>\n"},"faq":[{"question":"GoodRx hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"GoodRx hisselerini sat\u0131n almak i\u00e7in NASDAQ eri\u015fimi sunan bir yat\u0131r\u0131m platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, g\u00fcncel fiyat\u0131 ara\u015ft\u0131r\u0131n, limit emri verin ve pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc kontrol edin."},{"question":"GoodRx'in gelecekteki fiyat tahmini nedir?","answer":"Analistlere g\u00f6re 2025 sonunda $7.86, 2026'da $17.21 ve 2030'da $40-50 aral\u0131\u011f\u0131nda fiyat hedefleri bulunmaktad\u0131r."},{"question":"GoodRx hisselerinin riskleri nelerdir?","answer":"D\u00fczenleyici de\u011fi\u015fiklikler, eczane sekt\u00f6r\u00fcndeki istikrars\u0131zl\u0131k, y\u00fcksek volatilite ve ekonomik durgunluklar ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar GoodRx hisseleri i\u00e7in ne yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck miktarda ba\u015flay\u0131n, kazan\u00e7 uyar\u0131lar\u0131 kurun, limit emirleri kullan\u0131n, portf\u00f6y\u00fcn\u00fczde %5'in alt\u0131nda tutun ve sekt\u00f6r haberlerini takip edin."},{"question":"Pocket Option GoodRx yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC do\u011frulamas\u0131 ve \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ile volatiliteyi yakalamak i\u00e7in ideal bir platformdur."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"GoodRx hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"GoodRx hisselerini sat\u0131n almak i\u00e7in NASDAQ eri\u015fimi sunan bir yat\u0131r\u0131m platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, g\u00fcncel fiyat\u0131 ara\u015ft\u0131r\u0131n, limit emri verin ve pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc kontrol edin."},{"question":"GoodRx'in gelecekteki fiyat tahmini nedir?","answer":"Analistlere g\u00f6re 2025 sonunda $7.86, 2026'da $17.21 ve 2030'da $40-50 aral\u0131\u011f\u0131nda fiyat hedefleri bulunmaktad\u0131r."},{"question":"GoodRx hisselerinin riskleri nelerdir?","answer":"D\u00fczenleyici de\u011fi\u015fiklikler, eczane sekt\u00f6r\u00fcndeki istikrars\u0131zl\u0131k, y\u00fcksek volatilite ve ekonomik durgunluklar ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar GoodRx hisseleri i\u00e7in ne yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck miktarda ba\u015flay\u0131n, kazan\u00e7 uyar\u0131lar\u0131 kurun, limit emirleri kullan\u0131n, portf\u00f6y\u00fcn\u00fczde %5'in alt\u0131nda tutun ve sekt\u00f6r haberlerini takip edin."},{"question":"Pocket Option GoodRx yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC do\u011frulamas\u0131 ve \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi ile volatiliteyi yakalamak i\u00e7in ideal bir platformdur."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>GoodRx Holdings, Inc. (GDRX) Hisseleri Nas\u0131l Al\u0131n\u0131r - GoodRx Holdings, Inc. (GDRX) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GoodRx Holdings, Inc. (GDRX) Hisseleri Nas\u0131l Al\u0131n\u0131r - GoodRx Holdings, Inc. (GDRX) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T14:49:43+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"GoodRx Holdings, Inc. (GDRX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; GoodRx Holdings, Inc. (GDRX) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-25T14:49:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/\",\"name\":\"GoodRx Holdings, Inc. (GDRX) Hisseleri Nas\u0131l Al\u0131n\u0131r - GoodRx Holdings, Inc. (GDRX) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"datePublished\":\"2025-08-25T14:49:43+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GoodRx Holdings, Inc. (GDRX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; GoodRx Holdings, Inc. (GDRX) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"GoodRx Holdings, Inc. (GDRX) Hisseleri Nas\u0131l Al\u0131n\u0131r - GoodRx Holdings, Inc. (GDRX) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/","og_locale":"tr_TR","og_type":"article","og_title":"GoodRx Holdings, Inc. (GDRX) Hisseleri Nas\u0131l Al\u0131n\u0131r - GoodRx Holdings, Inc. (GDRX) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T14:49:43+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"GoodRx Holdings, Inc. (GDRX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; GoodRx Holdings, Inc. (GDRX) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-25T14:49:43+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/","name":"GoodRx Holdings, Inc. (GDRX) Hisseleri Nas\u0131l Al\u0131n\u0131r - GoodRx Holdings, Inc. (GDRX) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","datePublished":"2025-08-25T14:49:43+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-goodrx-holdings\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"GoodRx Holdings, Inc. (GDRX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; GoodRx Holdings, Inc. (GDRX) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":348651,"slug":"how-to-buy-goodrx-holdings","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/"},"pt_AA":{"locale":"pt_AA","id":348646,"slug":"how-to-buy-goodrx-holdings","post_title":"Como comprar a\u00e7\u00f5es da GoodRx Holdings, Inc. (GDRX) - Investimento em a\u00e7\u00f5es da GoodRx Holdings, Inc. (GDRX)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-goodrx-holdings\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/348645","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=348645"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/348645\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334126"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=348645"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=348645"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=348645"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}